The Oral Bioavailability of Peptides and Related Drugs
Reference51 articles.
1. Adibi, S. A., and Morse, E. L., 1977, The number of glycine residues which limit intact absorption of glycine oligopeptides in human jejunum, J. Clin. Invest., 60: 1008. 2. Allen, J. G., Havas, L., Leicht, E., Lenox-Smith, J., and Nisbet L. J., 1979, Phosphonopeptides as antibacterial agents: metabolism and pharmacokinetics of alafosfalin in animals and humans, Antimicrob. Agents, Chemo., 16: 306. 3. Atherton, F. A., Hall, M. J., Hasall, C. H., Holmes, S. W., Lambert, R. W., Lloyd, W. J., and Ringrose, P. S., 1980, Phosphonopeptide antibacterial agents related to alafosfalin: design, synthesis and structure-activity relationships, Antimicrob. Agents. Chemo., 18: 897. 4. Bell, J., Peters, G. E., McMartin, C., Thomas, N. W., and Wilson, C. G., 1984, Estimation of gut absorption of peptides by biliary sampling, J. Pharm. Pharmacol., 36: 88P. 5. Burston, D., Taylor, E., and Matthews, D. M., 1979, Intestinal handling of two tetrapeptides by rodent small intestine in vitro, Biochem. Biophy. Acta., 553: 175.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|